This is an old revision of this page, as edited by Beetstra (talk | contribs) at 14:45, 19 September 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'StdInChI', 'StdInChIKey').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:45, 19 September 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'StdInChI', 'StdInChIKey').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Terbogrel" – news · newspapers · books · scholar · JSTOR (May 2010) (Learn how and when to remove this message) |
Names | |
---|---|
IUPAC name (5E)-6-{3-phenyl}-6-pyridin-3-ylhex-5-enoic acid | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChemSpider | |
KEGG | |
PubChem CID | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C23H27N5O2 |
Molar mass | 405.49 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references |
Terbogrel blocks thromboxanes and is expected to be useful in treating the vasoconstricting and platelet aggregating action of this compound. Terbogrel is a thromboxane A2 receptor antagonist.
Se also: Ramatroban
Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antiplatelet drugs |
| ||||||||||||||
Anticoagulants |
| ||||||||||||||
Thrombolytic drugs/ fibrinolytics | |||||||||||||||
Non-medicinal | |||||||||||||||
|